The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity (NCT06494878)
The PARTUM (Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity) Trial
🩺 Plain-English Summary (8th-Grade Level)
The goal of the PARTUM trial is to determine if taking low-dose aspirin daily for 6 weeks after delivery is similar (non-inferior) to usual care low-molecular-weight heparin injections to prevent venous thromboembolism (VTE: blood clots in the legs or lungs) for postpartum individuals with VTE risk factors.
Who can join: Review the eligibility criteria below.
Location: Association Hospitalière De Bruxelles Et De Schaerbeek - Centre Hospitalier Universitaire Brugmann — Brussels
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (12 Sites)
- Association Hospitalière De Bruxelles Et De Schaerbeek - Centre Hospitalier Universitaire Brugmann — Brussels,
- Foothills Medical Centre — Calgary, Alberta
- The Ottawa Hospital - General Campus — Ottawa, Ontario
- Hvidovre Hospital — Hvidovre, Capital Region
- CHU de Nancy — Nancy,
- APHP - Hôpital Port Royal — Paris,
- CHU de Saint-Etienne — Saint-Etienne,
- CHU de Toulouse — Toulouse,
- Rotunda Hospital, RCSI Department of Obstetrics and Gynaecology — Dublin,
- UCD Centre for Human Reproduction, The Coombe Hospital — Dublin,
- Amsterdam UMC — Amsterdam,
- Medical University of Warsaw — Warsaw,
📞 Contact the Study Coordinator
Phone: (403) 944-5246
Email: laskeith@ucalgary.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Venous Thromboembolism
- Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery — Charleston, South Carolina
- Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism — Basking Ridge, New Jersey
- Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty — Miami, Florida
- Primary Thromboprophylaxis in Patients With Malignancy and Central Venous Catheters — Halifax, Nova Scotia
- DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis — Scottsdale, Arizona
- Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis — Ottawa, Ontario
Explore by condition: All Venous Thromboembolism clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.